Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Novavax Inc. buy jomobb

Novavax Inc.
Start price
€125.18
28.05.21 / 80%
Target price
€200.00
28.05.22
Performance (%)
-35.69%
End price
€80.50
29.01.22
Summary
This prediction ended on 29.01.22 with a price of €80.50. Massive losses of -35.69% were the result for the BUY prediction by jomobb. jomobb has 80% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Novavax Inc. 8.189% 8.189% -4.504% 4.028%
iShares Core DAX® 2,57 % 5,33 % 8,27 % 63,86 %
iShares Nasdaq 100 4,86 % 0,45 % 27,08 % 86,27 %
iShares Nikkei 225® 5,59 % -0,59 % 48,55 % 78,35 %
iShares S&P 500 3,25 % 2,50 % 23,35 % 68,71 %

According to jomobb what are the pros and cons of Novavax Inc. for the foreseeable future?

Pros
Top 10 in its market
Very Future proof/growth oriented business model
Leading role in innovation
Some uniques
Cons
Significant cyclical dependencies

Comments by jomobb for this prediction

In the thread Novavax Inc. diskutieren
Prediction Buy
Perf. (%) -35.69%
Target price 200.000
Change
Ends at 28.05.22

Kombi-Impfstoff

jomobb 
1
Report Share
28.05.21